15/12/21 – Alderley Park Accelerator
Apeikon is extremely pleased to be awarded first prize in the Alderley Park Accelerator programme.
Our technology is image-guided targeted drug delivery.
Our mission is to create targeted drug treatments.
Our vision is to make anti-cancer treatments safer and more effective.
Apeikon is extremely pleased to be awarded first prize in the Alderley Park Accelerator programme.
An article was published about Apeikon Therapeutics on the Science Entrepreneur Club. See: https://www.science-entrepreneur.com/blog-1/apeikon-therapeutics-tackling-the-side-effects-of-chemotherapy
Acceptance into the SETsquared ICURe programme. This 4-month programme is sponsored by an Innovate UK which focuses on bridging the gap between academia and industry for realistic, innovative answers needed …
Let us know if you are interested in our technology!